Hemolytic mutants of group A Streptococcus pyogenes

Area of Science:

• Microbiology
• Molecular Biology
• Pathogenesis

Background:

• Streptococcus pyogenes is a significant human pathogen.
• Hemolytic activity is a key characteristic of virulent S. pyogenes strains.
• Streptolysin S (SLS) is a major cytotoxin implicated in S. pyogenes virulence.

Purpose of the Study:

• To generate and characterize hemolytic mutants of Streptococcus pyogenes.
• To investigate the role of streptolysin S in S. pyogenes pathogenicity.
• To assess the stability of the induced hemolytic phenotype.

Main Methods:

• Chemical mutagenesis of S. pyogenes strains (Lancefield SS-95, ATCC 19615) using N-methyl-N'-nitro-N-nitrosoguanidine.
• Quantification of extracellular toxins: streptolysin O (SLO), nicotinamide adenine dinucleotidase (NADase), deoxyribonuclease (DNase), and hyaluronidase.
• Assessment of hemolytic activity and determination of streptolysin S (SLS) deficiency.
• Pathogenicity testing in a mouse model.
• Reisolation and characterization of S. pyogenes from infected animals.

Main Results:

• Hemolytic mutants were successfully generated.
• Mutants exhibited deficiency in streptolysin S (SLS), similar to the naturally nonhemolytic Lowry strain.
• Levels of streptolysin O (SLO), NADase, DNase, and hyaluronidase remained comparable to wild-type strains.
• Mutants retained pathogenicity in mice.
• Reisolated mutants from infected mice exhibited the same hemolytic deficiency.

Conclusions:

• Streptolysin S (SLS) is essential for the characteristic hemolytic activity of Streptococcus pyogenes.
• Deficiency in SLS does not abolish the pathogenicity of S. pyogenes in a mouse model.
• The generated mutants provide valuable tools for studying S. pyogenes virulence factors.
• The hemolytic phenotype of the induced mutants is stable and heritable.